Table 3.
Outcome and exposure categories | Number of cases | Model 1a IRR (95% CI) | Model 2b IRR (95% CI) | Model 3c IRR (95% CI) |
---|---|---|---|---|
All cancer subtypes combined | ||||
No maternal diabetes | 8,709 | Reference | Reference | Reference |
Maternal diabetes | 130 | 1.11 (0.94, 1.32) | 1.10 (0.92, 1.30) | 1.06 (0.89, 1.26) |
CBT | ||||
No maternal diabetes | 2,063 | Reference | Reference | Reference |
Maternal diabetes | 16 | 0.59 (0.36, 0.96) | 0.59 (0.36, 0.97) | 0.56 (0.35, 0.91) |
Leukemiad | ||||
No maternal diabetes | 2,631 | Reference | Reference | Reference |
Maternal diabetes | 56 | 1.57 (1.20, 2.04) | 1.52 (1.16, 1.98) | 1.47 (1.13, 1.92) |
ALL | ||||
No maternal diabetes | 2,043 | Reference | Reference | Reference |
Maternal diabetes | 48 | 1.73 (1.30, 2.30) | 1.67 (1.25, 2.22) | 1.64 (1.23, 2.18) |
Lymphoma | ||||
No maternal diabetes | 884 | Reference | Reference | Reference |
Maternal diabetes | 17 | 1.48 (0.92, 2.39) | 1.43 (0.88, 2.31) | 1.45 (0.90, 2.36) |
Notes: Estimated using Cox proportional hazards models.
Unadjusted estimates.
Adjusted for child’s sex, decade of birth, maternal age, highest attained parental education level, and birth order.
Adjusted for child’s sex, decade of birth, maternal age, highest attained parental education level, birth order, birth weight by gestational age, gestational age, child’s diabetes status, and child birth defects.
All types of leukemia combined.
Abbreviations: IRRs, incidence rate ratios; CIs, confidence intervals; CBT, childhood brain tumor; ALL, acute lymphoblastic leukemia.